Recordati Industria Chimica e Farmaceutica S.p.A., doing business as Recordati SpA, manufactures pharmaceuticals. The Company researches, develops, manufactures, and markets prescription and non-prescription pharmaceuticals, pharmaceutical chemicals, therapeutic products, and rare disease treatments. The Company sells its products throughout the world.

Revenue(RF), mln.USD
Staff(RF), 2021
Capital(RF), mln.USD
Assets(RF), mln.USD
Glob.Revenue, mln.USD

Russia had an exceptionally busy season for coughs and colds, with sales there up 40% in the 1Q2023. Russia, Ukraine and other CIS countries accounted for just over 7% of annual sales last year, according to the company’s annual report.

The Company Statement
May 11, 2023

Italy's Recordati boosted by strong sales in Russia. Italian drug maker Recordati benefited from strong demand in markets such as Turkey and Russia in the first three months of the year, its chief executive said on May 11, 2023 after the company lifted its annual revenue and profit targets. Koremans said that Recordati did not produce any products in Russia but continued to import treatments for rare diseases, as well as prescription drugs for more routine conditions.

June 24, 2022Recordati Industria Chimica E Farmaceutica Spa | See Full Import/Export History | ImportGenius
Our Offices - Recordati
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.